#drug pricing

Several makers of hepatitis C drugs are limiting health care providers’ access to the 340B Drug Pricing Program’s discounts.

Yes! The Mark Cuban Cost Plus Drug Company sells cheaper generic drugs for diabetes, cancer, high blood pressure, HIV, hepatitis and more.

A letter from 124 patient groups urges the White House to make drugs more affordable—and spells out how it can do so.

A new lawsuit accuses the imprisoned hedge funder of blocking generic rivals of an AIDS-related drug.

Over 60 drugmakers raised prices an average of 5.8% on hundreds of drugs.

I am very aware of the difficulties faced by people in the USA, where Big Pharma artificially inflates the price of critical medicines.

Oncologist wins Senate backing by a vote of 72 to 18.

A look at what the law says about buying prescription drugs from Canada.

Insurance companies can no longer implement harmful co-pay accumulator policies.

In fact, antiviral drugs account for nearly 14 percent of total drug costs in the program.

Stop me if you’ve heard this one before.

A look at the 2019 State of the Union address

Louisiana health officials are adopting the country’s first subscription model for hep C cures.

Older drugs, many on the market for years, are rising in cost much faster than inflation.

A new study examines the clinical and economic impact of new direct-acting antivirals.

New recommendations in the Annals of Internal Medicine would increase access to treatment.